Theravance Biopharma

TBPH NASDAQ
Overview Stats Financials News

Quarterly Financials

Values in thousands 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Revenue $17,565 $15,693 $13,749 $10,417
Gross Profit 13,232 14,354 12,411 8,761
EBITDA -3,333 -6,974 -12,450 -20,359
EBIT -4,750 -8,760 -16,123 -24,912
Net Income -8,511 -8,950 -15,645 -22,088
Net Change In Cash 17,565 15,693 13,749 10,417
Cost of Revenue -82,069 -110,507
Free Cash Flow -1,531 -2,507 -13,288 -12,159
Cash 39,545 71,685 -42,521 187,665
Basic Shares 49,415 52,361 56,682 62,934

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $57,424 $51,346 $55,311 $71,857
Gross Profit 51,372 44,757 48,025 -189,095
EBITDA -40,277 -70,574 -132,546 -226,488
EBIT -44,533 -91,957 -257,784 -297,757
Net Income -55,193 -92,824 -199,426 -278,017
Net Change In Cash 57,424 51,346 55,311 71,857
Cost of Revenue 208,212 8,496 23,403
Free Cash Flow -29,485 -187,563 -211,264 -257,019
Cash 39,545 298,172 89,959 81,467
Basic Shares 55,303 73,591 69,461 62,345

Earnings Calls

Quarter EPS
2023-12-31 -$0.17
2023-09-30 -$0.17
2023-06-30 -$0.28
2023-03-31 -$0.35